Bahrain approves Sinopharm vaccine for children aged 3-11

1 minute read

Doses of the Chinese Sinopharm vaccine against the coronavirus disease (COVID-19) are seen at a restaurant in Kragujevac, Serbia, May 4, 2021. REUTERS/Marko Djurica/File Photo

Register now for FREE unlimited access to Reuters.com

DUBAI, Oct 26 (Reuters) - Bahrain has approved the Sinopharm COVID-19 vaccine for children aged between 3 and 11 years from October 27, the state media office said on Tuesday.

The Pfizer COVID-19 vaccine would soon be approved for children between 5 and 11, it also said.

Register now for FREE unlimited access to Reuters.com
Reporting by Alexander Cornwell; Editing by Andrew Cawthorne

Our Standards: The Thomson Reuters Trust Principles.